Drug Policy Alliance
Not-for-profit organization seeking to reduce the harms of drug use and drug prohibition
Based in NY
🤖
AI Overview
With $40K in lobbying spend across 8 quarterly filings, Drug Policy Alliance is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2021 to 2022.
$40K
Total Spend
2
Years Active
1
Firms Hired
4
Lobbyists Deployed
4
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $30K |
| 2022 | $10K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Civil Rights, District of Columbia, Health Issues, Law Enforcement
- •Federal government removal of the District of Columbia budget rider that prohibits the District of Columbia from amending its drug laws relating to substances on the Schedule I drug list.
- •Federal government removal of the District of Columbia budget rider that prohibits the District of Columbia from amending its drug laws relating to substances on the Schedule I drug list
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.